Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon
- 1 May 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (10) , 1257-1262
- https://doi.org/10.1016/s0960-894x(01)80341-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.Circulation, 1992
- Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation.Circulation, 1991
- Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?Annals of Internal Medicine, 1991
- Plasma immunoreactive endothelin in essential hypertensionThe American Journal of Medicine, 1990
- Plasma endothelin levels in hypertension and chronic renal failure.Hypertension, 1990
- RAISED PLASMA ENDOTHELIN IN ANEURYSMAL SUBARACHNOID HAEMORRHAGEThe Lancet, 1989
- Endothelin-3 is a novel neuropeptide: Isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brainBiochemical and Biophysical Research Communications, 1989
- Abundance of endothelin-3 in rat intestine, pituitary gland and brainBiochemical and Biophysical Research Communications, 1989
- The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.Proceedings of the National Academy of Sciences, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988